KALV KalVista Pharmaceuticals, Inc.
Healthcare$26.81+0.07%ClosedMarket Cap: $1.43B
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
8
Dispositions
16
Buy/Sell Ratio
0.50
Net Shares
-22,551
Shares Acquired
52,794
Shares Disposed
75,345
Total Bought ($)
$0.00
Total Sold ($)
$8.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Tue May 19 | Yea Christopher | officer: CHIEF DEVELOPMENT OFFICER | Sell | 1,108 | $26.76 | 227,367 |
| Tue May 19 | Yea Christopher | officer: CHIEF DEVELOPMENT OFFICER | Sell | 1,774 | $0.00 | 228,475 |
| Tue May 19 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 1,129 | $26.76 | 467,665 |
| Tue May 19 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 2,419 | $0.00 | 468,794 |
| Tue May 19 | Audhya Paul K. | officer: CHIEF MEDICAL OFFICER | Sell | 1,032 | $26.76 | 143,934 |
| Tue May 19 | Audhya Paul K. | officer: CHIEF MEDICAL OFFICER | Sell | 2,419 | $0.00 | 144,966 |
| Wed May 13 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 3,322 | $26.71 | 466,375 |
| Wed May 13 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 7,120 | $0.00 | 469,697 |
| Mon Apr 20 | Sweeny Nicole | officer: Chief Commercial Officer | Sell | 1,862 | $20.22 | 51,391 |
| Mon Apr 20 | Sweeny Nicole | officer: Chief Commercial Officer | Sell | 6,250 | $0.00 | 93,750 |
| Mon Apr 20 | Piekos Brian | officer: Chief Financial Officer | Sell | 1,862 | $20.22 | 18,150 |
| Mon Apr 20 | Piekos Brian | officer: Chief Financial Officer | Sell | 6,250 | $0.00 | 93,750 |
| Mon Apr 20 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 20,312 | $0.00 | 472,127 |
| Mon Apr 20 | Audhya Paul K. | officer: CHIEF MEDICAL OFFICER | Sell | 2,686 | $20.22 | 142,547 |
| Mon Apr 20 | Audhya Paul K. | officer: CHIEF MEDICAL OFFICER | Sell | 6,250 | $0.00 | 145,233 |